(AGENPARL) – SILVER SPRING mar 02 maggio 2023 Information on FDA’s Framework for the Regulation of Regenerative Medicine Products Fonte/Source: http://www.fda.gov/vaccines-blood-biologics/cellular-gene-therapy-products/resources-related-regenerative-medicine-therapies
Browsing: regenerative
(AGENPARL) – SILVER SPRING mer 19 aprile 2023 Eligibility requirements for a regenerative medicine advanced therapy (RMAT) designation. Information on when…
(AGENPARL) – SILVER SPRING gio 06 aprile 2023 The FDA’s Center for Biologics Evaluation and Research (CBER) Office of Therapeutic Products…